Novartis/BMS deal closes
This article was originally published in The Tan Sheet
Executive Summary
Swiss firm completes $385 mil. strategic acquisition of Mead Johnson's global adult nutritionals business from Bristol-Meyers Squibb Feb. 13. Novartis said the all-cash deal did not require any divestments for regulatory approval. The firms announced the deal in December (1"The Tan Sheet" Dec. 22, 2003, p. 12)...